South Africa will put on hold use of AstraZeneca’s COVID-19 shot in its vaccination program, after data showed it gave minimal protection against mild-to-moderate infection caused by the country’s dominant coronavirus variant.
Suscribirse a:
Enviar comentarios (Atom)
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook